CJC-1295 (W/O DAC) + IPAMORELIN (10 MG)

Product Overview

CJC-1295 (5mg, No DAC) + Ipamorelin (5mg) is a dual-peptide research combination studied for its synergistic role in promoting endogenous growth hormone (GH) release, recovery, and metabolic balance.
In controlled research settings, this pairing allows investigators to examine how short-acting GHRH analogs and selective ghrelin agonists interact to stimulate natural pituitary function and downstream IGF-1 activity without exogenous hormone replacement.

CJC-1295 (No DAC) is a growth hormone–releasing hormone (GHRH) analog that lacks the Drug Affinity Complex (DAC) modification, giving it a shorter half-life and more physiological GH pulse profile.
Because it mimics the body’s own timing of GH secretion, the No DAC version is favored in studies seeking to replicate natural circadian hormone rhythms and transient pituitary activation.
Researchers use CJC-1295 No DAC to explore acute GH release, IGF-1 expression, and cellular recovery mechanisms across endocrine and metabolic systems.

Ipamorelin complements this by acting as a growth hormone secretagogue (GHS) that binds to ghrelin receptors (GHSR-1a) in the pituitary gland, triggering a rapid yet selective GH pulse.
Unlike other GHS compounds, Ipamorelin is recognized for its high receptor specificity, producing minimal effect on cortisol or prolactin, which allows for cleaner, more targeted research outcomes.

When combined, CJC-1295 No DAC and Ipamorelin create a powerful dual-pathway model for examining both hypothalamic and pituitary signaling.
Researchers utilize this pairing to investigate potential effects on muscle growth, tissue repair, sleep quality, fat metabolism, and cellular regeneration—key areas of interest in modern peptide and longevity research.

Key Research Benefits

• Studied for its synergistic stimulation of natural growth hormone release

• Supports research into pituitary signaling, IGF-1 modulation, and cellular recovery

• May aid in understanding muscle repair, fat metabolism, and sleep-related hormone patterns

• Explored for its ability to replicate physiological GH pulses without exogenous hormone administration

• Demonstrates short, controlled activity ideal for circadian or timing-based peptide research

⚠️ Disclaimer

All products, including CJC-1295 (No DAC) + Ipamorelin, are sold for laboratory and research purposes only.
Not for human consumption, medical, or veterinary use.